Amin Amin1, Asad Ali2, Quratul A Altaf3, Milan K Piya4,5, Anthony H Barnett1,3,6, Neil T Raymond7, Abd A Tahrani1,3. 1. Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom. 2. Department of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom. 3. Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom. 4. Department of Diabetes, Derby Teaching Hospitals NHS Foundation NHS Trust, Derby, United Kingdom. 5. Warwick Medical School, University of Warwick, Coventry, United Kingdom. 6. Centre of Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom. 7. Independent Epidemiology and Statistical Consultant, Epidemiology, Research Design and Statistical Consulting (ERDASC), Leicestershire, United Kingdom.
Abstract
STUDY OBJECTIVES: To assess and compare obstructive sleep apnea (OSA) prevalence in South Asians and White Europeans with type 2 diabetes mellitus (T2DM). Secondary aims included exploring possible causes for observed ethnic differences. METHODS: A cross-sectional study of patients with T2DM recruited from secondary care diabetes clinics. OSA was defined as an apnea-hypopnea index (AHI) ≥ 5 events/h using home-based, multi-channel respiratory monitoring. RESULTS: Two hundred thirty-four patients (105 South Asian and 129 White Europeans) were studied. The prevalence of mild, moderate, and severe OSA in South Asians was 36.2% (n = 38/105), 9.5% (n = 10/105), and 5.7% (n = 6/105) respectively. After adjustment, OSA was associated with a higher body mass index in South Asians. OSA was significantly less common in South Asians compared to White Europeans (51.4% [54/105] versus 75.2% [97/129], P < .001). OSA was also less severe in South Asians compared to White Europeans (median [interquartile range]: AHI 5.1 [1.4-11.5] versus 8.5 [5.0-20.7] events/h, P < .001; time spent with oxygen saturations < 90% 0.5 [0.0-2.9]% versus 4.0 [0.7-14.4]%, P < .001). Logistic regression showed that only obesity measures explained the ethnic differences in OSA. CONCLUSIONS: South Asians with T2DM are at considerable risk of OSA. OSA in South Asians was associated with obesity. However, OSA prevalence was lower in South Asians than in White Europeans. Obesity measures accounted for the observed ethnic differences. Examining factors contributing to ethnic differences will be important to inform screening and treatment strategies.
STUDY OBJECTIVES: To assess and compare obstructive sleep apnea (OSA) prevalence in South Asians and White Europeans with type 2 diabetes mellitus (T2DM). Secondary aims included exploring possible causes for observed ethnic differences. METHODS: A cross-sectional study of patients with T2DM recruited from secondary care diabetes clinics. OSA was defined as an apnea-hypopnea index (AHI) ≥ 5 events/h using home-based, multi-channel respiratory monitoring. RESULTS: Two hundred thirty-four patients (105 South Asian and 129 White Europeans) were studied. The prevalence of mild, moderate, and severe OSA in South Asians was 36.2% (n = 38/105), 9.5% (n = 10/105), and 5.7% (n = 6/105) respectively. After adjustment, OSA was associated with a higher body mass index in South Asians. OSA was significantly less common in South Asians compared to White Europeans (51.4% [54/105] versus 75.2% [97/129], P < .001). OSA was also less severe in South Asians compared to White Europeans (median [interquartile range]: AHI 5.1 [1.4-11.5] versus 8.5 [5.0-20.7] events/h, P < .001; time spent with oxygen saturations < 90% 0.5 [0.0-2.9]% versus 4.0 [0.7-14.4]%, P < .001). Logistic regression showed that only obesity measures explained the ethnic differences in OSA. CONCLUSIONS: South Asians with T2DM are at considerable risk of OSA. OSA in South Asians was associated with obesity. However, OSA prevalence was lower in South Asians than in White Europeans. Obesity measures accounted for the observed ethnic differences. Examining factors contributing to ethnic differences will be important to inform screening and treatment strategies.
Authors: Fahad Razak; Sonia S Anand; Harry Shannon; Vladimir Vuksan; Bonnie Davis; Ruby Jacobs; Koon K Teo; Matthew McQueen; Salim Yusuf Journal: Circulation Date: 2007-04-09 Impact factor: 29.690
Authors: Helaine E Resnick; Susan Redline; Eyal Shahar; Adele Gilpin; Anne Newman; Robert Walter; Gordon A Ewy; Barbara V Howard; Naresh M Punjabi Journal: Diabetes Care Date: 2003-03 Impact factor: 19.112
Authors: Zarir F Udwadia; Amita V Doshi; Sharmila G Lonkar; Chandrajeet I Singh Journal: Am J Respir Crit Care Med Date: 2003-11-06 Impact factor: 21.405
Authors: Shazia Jehan; Ferdinand Zizi; Seithikurippu R Pandi-Perumal; Steven Wall; Evan Auguste; Alyson K Myers; Girardin Jean-Louis; Samy I McFarlane Journal: Sleep Med Disord Date: 2017-12-12
Authors: Quratul A Altaf; Paul Dodson; Asad Ali; Neil T Raymond; Helen Wharton; Hannah Fellows; Rachel Hampshire-Bancroft; Mirriam Shah; Emma Shepherd; Jamili Miah; Anthony H Barnett; Abd A Tahrani Journal: Am J Respir Crit Care Med Date: 2017-10-01 Impact factor: 21.405
Authors: Shazia Jehan; Alyson K Myers; Ferdinand Zizi; Seithikurippu R Pandi-Perumal; Girardin Jean-Louis; Samy I McFarlane Journal: Sleep Med Disord Date: 2018-06-21